日本語 
MNES and I’ROM Group have entered into a strategic partnership focused on digital transformation in clinical research and clinical trials. MNES provides the cloud-based medical information management and sharing system LOOKREC. I’ROM Group is one of Japan’s largest SMOs supporting pharmaceutical development. The partnership is aimed at improving efficiency in clinical trials and research while building a medical data ecosystem centered on a medical DX platform.
Through this collaboration, the two companies plan to connect their networks. About 1,700 medical facilities already using LOOKREC will be linked with roughly 4,500 clinical trial institutions supported by I’ROM Group. The idea is to form an integrated clinical development network that makes trials easier to run and participation easier to scale across Japan.
The background information presents clear evidence that Japan currently faces three main issues which include a shortage of medical staff and insufficient healthcare access and the enforcement of work style reforms. The clinical research field continues to experience operational difficulties because its systems remain uncoordinated and inefficient. IRB reviews can take two to three months. Each facility reviews separately. Documents are still handled in analog ways.
Also Read: Opt Fit Unveils “And L Work” for Corporate Health Support
At the same time, the government is pushing Healthcare DX under the Reiwa Vision 2030. Electronic medical record standardization, secondary use of medical data, decentralized clinical trials, and GCP guidance revisions are all moving forward.
Under the partnership, MNES and I’ROM Group will expand the clinical development network through mutual service introductions and patient recruitment support. The team will develop digital solutions for clinical development operations through their implementation of cloud technology and artificial intelligence and data analytics tools. The organization plans to establish an integrated institutional review board system together with a worldwide clinical trial data repository which will enable them to decrease review durations while achieving complete digitization of trial operations by the year 2030.
English